Company profile: Alderys
1.1 - Company Overview
Company description
- Provider of innovative biological engineering approaches to produce chemical compounds of economic interest from renewable plant resources, including nutrients via rectified biosynthetic routes, targeting convenience chemicals, cosmetics, and animal nutrition markets, with environmentally respectful industrial technological solutions.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Alderys
Brooks Running
HQ: United States
Website
- Description: Provider of automation, vacuum, and instrumentation solutions for the worldwide semiconductor manufacturing industry, including wafer handling robotics and integrated tool automation systems, vacuum and atmospheric robots, configurable transfer and transport platforms (MagnaTran LEAP, Marathon LEAP AX, Marathon Express), and pathology lab automation (PathFinder Benchtop, Tube Decapper).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Brooks Running company profile →
Emulate
HQ: United States
Website
- Description: Provider of advanced in vitro models for understanding how diseases, medicines, chemicals, and foods affect human health.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Emulate company profile →
A4Cell
HQ: Spain
Website
- Description: Provider of SPAchip technology using intracellular silicon microchips to monitor living single cells and cellular pathways in real time without affecting viability. Offers kits: CytoCHECK pH Green, pH Red, Calcium; CytoTRACK pH Dual-Detection; and SpheroCHECK pH Green for 3D spheroids, enabling precise single-cell physiology monitoring to improve cell study data for understanding disease behavior.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full A4Cell company profile →
Novoheart
HQ: Canada
Website
- Description: Provider of stem cell and bioengineering platforms and services for cardiac drug discovery, including the MyHeart/mini-Heart Platform of engineered human cardiomyocyte tissues for assessing cardiac functional outputs in pre-clinical and clinical trials; the Human Heart-in-a-Jar (hvCOC); hvCAS for electrophysiology, arrhythmia, contractility and pressure-volume; the mini-Life multi-organ system; and custom drug discovery, cardiotoxicity screening, disease modeling, efficacy and dose titration.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Novoheart company profile →
InGeneron
HQ: United States
Website
- Description: Provider of autologous, evidence-based cell therapy solutions, including the Transpose RT System to isolate regenerative cells from a patient's adipose tissue for same-day treatment of various conditions, and clinical trials evaluating such therapies for rotator cuff tendinopathy, facet joint syndrome, and wrist osteoarthritis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full InGeneron company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Alderys
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Alderys
2.2 - Growth funds investing in similar companies to Alderys
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Alderys
4.2 - Public trading comparable groups for Alderys
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →